메뉴 건너뛰기




Volumn 52, Issue 3, 2001, Pages 201-204

Guidelines for therapy with cyclosporine in dermatology: Compiled by the Concensus Conference on Cyclosporine;Leitlinien zur therapie mit ciclosporin in der dermatologie: Erarbeitet durch die Konsensus-Konferenz Ciclosporin

(1)  Mrowietz, U a  

a NONE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIPOTRIOL; CYCLOSPORIN; DITHRANOL; SALICYLIC ACID; TACALCITOL; TAZAROTENE;

EID: 0035099623     PISSN: 00178470     EISSN: None     Source Type: Journal    
DOI: 10.1007/s001050051290     Document Type: Review
Times cited : (6)

References (23)
  • 2
    • 0027216070 scopus 로고
    • Vorstellungen zum Wirkmechanismus von Ciclosporin bei der Psoriasis
    • (1993) Hautarzt , vol.44 , pp. 353-360
    • Mrowietz, U.1
  • 7
    • 0031847245 scopus 로고    scopus 로고
    • A randomized, double-blind study comparing the efficacy, safety and optimal dose of two formulations of cyclosporin, Neoral® and Sandimmun®, in patients with severe psoriasis
    • (1998) Br J Dermatol , vol.139 , pp. 86-93
    • Koo, J.1
  • 8
    • 0031933038 scopus 로고    scopus 로고
    • Conversion of psoriasis patients from the conventional formulation of cyclosporin A to a new microemulsion formulation: A randomized, open, multicentre assessment of safety and tolerability
    • (1998) Dermatology , vol.196 , pp. 231-236
    • Zachariae, H.1    Abrams, B.2    Bleehen, S.S.3
  • 19
    • 0028037259 scopus 로고
    • Consensus statements on the optimal use of cydospo-rine in pediatric patients
    • (1994) Transplant Proc , vol.26 , pp. 2759-2762
    • Brodehl, J.1
  • 20
    • 0001938181 scopus 로고
    • Safety considerations with cyclosporin and other systemic therapy in the treatment of severe psoriasis. A comparative overview
    • (1995) Clin Drug Invest , vol.10 , Issue.SUPPL. 1 , pp. 36-44
    • Mrowietz, U.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.